Table 1.
Subject characteristics
| Control | CRSsNP | CRSwNP | Samter’s | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total no. of subjects | n=28 (14M) | n=55 (26M) | n=92 (65M) | n=12 (6M) | ||||||||
| Age (y), median (range) | 48* (16–63)# | 38 (18–64) | 43 (22–74) | 47 (26–61) | ||||||||
| Y | N | U | Y | N | U | Y | N | U | Y | N | U | |
| Atopy | 0 | 24 | 4 | 24 | 25 | 6 | 42 | 40 | 10 | 7 | 2 | 3 |
| Asthma | 0 | 27 | 2 | 12 | 33 | 10 | 40 | 51 | 1 | 12 | 0 | 0 |
| Methodologies used | UT | UT | UT | NP | NP | |||||||
| Tissue RNA | n=9 (3M) | n=18 (8M) | n=17 (14M) | n=24 (18M) | - | |||||||
| Age | 41 (16–59) | 36 (23–64) | 43 (26–61) | 44 (26–74) | - | |||||||
| Tissue Extract | n=15 (9M) | n=32 (15M) | n=29 (20M) | n=39 (28M) | n=12 (6M) | |||||||
| Age | 49 (19–63) | 37 (18–64) | 41 (18–67) | 41 (22–72) | 47 (26–61) | |||||||
| Immunofluorescence | n=11 (8M) | n=11 (6M) | n=11 (9M) | n=17 (11M) | - | |||||||
| Age | 53 (19–62) | 38 (21–61) | 48 (34–72) | 52 (22–70) | - | |||||||
median,
(range). M; male, Y; yes, N; no, U; unknown.